ASX Share rice
Thu 06 Aug 2020 - 12:12:am (Sydney)

PAR Share Price

PARADIGM BIOPHARMACEUTICALS LIMITED..PARPharmaceuticals, Biotechnology & Life Sciences

PAR Company Information


Paradigm Biopharmaceuticals Limited





GIC Industry:


GIC Sub Industry:



500 Collins Street Melbourne VIC Australia 3000


61 3 9629 5566

CEO, MD & Interim Exec. Chairman:

Mr. Paul Rennie B.Sc., BSc, Grad Dip, MBM, MSTC

CFO & Company Sec.:

Mr. Kevin G. Hollingsworth

Chief Operating Officer:

Dr. Jeannette Joughin

Chief Scientific Officer:

Dr. Ravi Krishnan

Director of Investor Relations:

Simon White

Company Overview:

Paradigm Biopharmaceuticals Limited, a biopharmaceutical company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulphate sodium drugs in the injectable and tablet forms for the treatment of bone marrow edema, respiratory, and alphaviral arthritis diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.

PAR Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


PAR CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Income:


Total Cash From Operating Activities:




Change To Account Receivables:


Sale Purchase Of Stock:


Capital Expenditures:


PAR Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Other Operating Expenses:


Total Revenue:


Total Operating Expenses:


PAR Balance Sheet

Balance Sheet Date:


Intangible Assets:


Total Liabilities:


Total Stockholder Equity:


Total Assets:


Common Stock:


Retained Earnings:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Net Receivables:


Short-Term Investments:


Accounts Payable:


Non Currrent Assets (Other):


Short-Term Investments:


Non Current Liabilities Total:


PAR Share Price History

PAR News

24 Mar, 2020
NEW YORK, NY / ACCESSWIRE / March 24, 2020 / Solebury Trout, a boutique investor relations and corporate communications firm, announced today that it will be hosting a Virtual Conference Series on March ...
13 Mar, 2020
It certainly might concern Paradigm Biopharmaceuticals Limited (ASX:PAR) shareholders to see the share price down 51...
11 Dec, 2019
There's no doubt that money can be made by owning shares of unprofitable businesses. Indeed, Paradigm...
04 Nov, 2019
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...
04 Oct, 2019
Investing can be hard but the potential fo an individual stock to pay off big time inspires us. Mistakes are...
08 Aug, 2019
Every investor in Paradigm Biopharmaceuticals Limited (ASX:PAR) should be aware of the most powerful shareholder...